Stocks
Wells Fargo Raises MRK Price Target to $170
Wells Fargo has maintained an Overweight rating on Merck & Co (MRK), with a recent price target increase to $170.00, marking a significant jump of 13.33% from its prior target of $150.00.
The move reflects growing confidence in MRK's future performance, particularly given its strong product portfolio and market position.
According to the GF Value™, Merck & Co is currently trading at $151.07, which is 25.9% above its intrinsic value of $120.03, indicating overvaluation.